News
Stealth secured a new agency review of its experimental therapy elamipretide after a rejection this year. The result could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback